Key result
Recombinant huntingtin subdomains reconstitute functional HTT structure and bind HAP40 with 10 nM affinity.
Why the study?
The biological role of wildtype huntingtin and mechanisms of disease pathology remain incompletely understood, partly due to challenges characterising interactions between huntingtin and binding partners.
Effect estimate: Kd 10 nM
The development of validated recombinant HTT subdomains provides a biochemical toolkit for studying HTT biology and discovering new binding partners in Huntington's disease research.
Supplies validated HTT subdomains for binding-partner screens; leaves open any therapeutic translation in Huntington's disease.
Huntington’s disease is characterised by CAG expansion in the huntingtin gene above a critical threshold of ~ 35 repeats, resulting in polyglutamine expansion of the huntingtin protein (HTT). The biological role of wildtype HTT and the associated mechanisms of disease pathology caused by expanded HTT remain incompletely understood, in part, due to challenges characterising interactions between HTT and putative binding partners. Here we describe a biochemical toolkit of rationally designed, high-quality recombinant HTT subdomains; one spanning the N-terminal HEAT and bridge domains (NTD) and the second spanning the C-terminal HEAT domain (CTD). Using biophysical methods and cryo-electron microscopy, we show these smaller subdomains are natively folded and can associate to reconstitute a functional full-length HTT structure capable of forming a near native-like complex with 40 kDa HTT-associated protein (HAP40). We report biotin-tagged variants of these subdomains, as well as full-length HTT, that permit immobilisation of each protein for quantitative biophysical assays without impacting protein quality. We demonstrate the CTD alone can form a stable complex when co-expressed with HAP40, which can be structurally resolved. The CTD-HAP40 complex binds the NTD, with a dissociation constant of approximately 10 nM as measured by bio-layer interferometry. We validate the interaction between the CTD and HAP40 using a luciferase two-hybrid assay and use subdomain constructs to demonstrate their respective stabilization of HAP40 in cells. These open-source biochemical tools will enable the wider HD community to study fundamental HTT biology, discover new macromolecular or small-molecule binding partners and map interaction sites across this very large protein.
No takes yet. Share an insight, caveat, or question.
Alteen et al. (2022) studied Huntington's disease (in vitro models). Recombinant HTT subdomain constructs (NTD and CTD) vs. Full-length HTT or tag-only controls was evaluated on Binding affinity (Kd) of CTD-HAP40 to NTD (Kd 10 nM). Rationally designed recombinant huntingtin subdomains (NTD and CTD) are natively folded, can reconstitute a functional full-length HTT structure, and bind HAP40 with a dissociation constant of 10 nM.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: